Interstitial pneumonia induced by combined intraarterial 5-fluorouracil and subcutaneous interferon-α therapy for advanced hepatocellular carcinoma

Journal of Gastroenterology

Volumn 39, Issue 8, 2004, Pages 793-797

  Yamamoto, Shinji ^a   Tomita, Yasuhiko ^a   Hoshida, Yoshihiko ^a   Iizuka, Norishige ^a   Marubashi, Shigeru ^a   Miyamoto, Atsushi ^a   Nagano, Hiroaki ^a   Dono, Keizo ^a   Umeshita, Koji ^a   Nakamori, Shoji ^a   Sakon, Masato ^a   Aozasa, Katsuyuki ^a   Monden, Morito ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

5 fluorouracil; Hepatocellular carcinoma; Interferon ; Interstitial pneumonia

Indexed keywords

ALPHA INTERFERON; ANTIBIOTIC AGENT; FLUOROURACIL; STEROID;

ADULT; ADVANCED CANCER; ARTICLE; ARTIFICIAL EMBOLISM; ATELECTASIS; AUTOPSY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; HEPATITIS C; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERSTITIAL PNEUMONIA; LABORATORY DIAGNOSIS; LIVER CELL CARCINOMA; LUNG INSUFFICIENCY; MALE; PRIORITY JOURNAL; THORAX RADIOGRAPHY; TUMOR VOLUME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, HEPATOCELLULAR; FATAL OUTCOME; FLUOROURACIL; HUMANS; INFUSIONS, INTRA-ARTERIAL; INJECTIONS, SUBCUTANEOUS; INTERFERON-ALPHA; LIVER NEOPLASMS; LUNG; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; NEOPLASM CIRCULATING CELLS; PORTAL VEIN; TOMOGRAPHY, X-RAY COMPUTED;

EID: 4644257202     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00535-004-1375-0     Document Type: Article

References (18)

1. Chapekar MS, Glazer RI. Effects of human immune interferon on cell viability, (2′, 5′) oligoadenylate synthesis, and polyamine-dependent protein phosphorylation in human colon carcinoma cells in vitro. Cancer Res 1984;44:2144-9.
2. Hirai N, Kato Y, Kobayashi K, Hattori N. Natural killer cell activity and its in vitro response to interferon-alpha(Le) in chronic liver diseases and hepatocellular carcinoma. Liver 1986;6: 212-20.
3. Miyamoto A, Umeshita K, Sakon M, Nagano H, Eguchi H, Kishimoto S, et al. Advanced hepatocellular carcinoma with distant metastases, successfully treated by a combination therapy of alpha-interferon and oral tegafur/uracil. J Gastroenterol Hepatol 2000;15:1447-51.
4. Sakon M, Nagano H, Dono K, Nakamori S, Umeshita K, Yamada A, et al. Combined intraarterial 5-fluorouracil and subcutaneous interferon-alpha therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branches. Cancer 2002; 94:435-42.
5. Wadler S, Wiernik PH. Clinical update on the role of fluorouracil and recombinant interferon alfa-2a in the treatment of colorectal carcinoma. Semin Oncol 1990;17:16-21.
6. Moriya K, Yasuda K, Koike K, Ichinose Y, Yotsuyanagi H, Kurokawa K, et al. Induction of interstitial pneumonitis during interferon treatment for chronic hepatitis C. J Gastroenterol 1994;29:514-7.
7. Okanoue T, Sakamoto S, Itoh Y, Minami M, Yasui K, Sakamoto M, et al. Side effects of high-dose interferon therapy for chronic hepatitis C. J Hepatol 1996;25:283-91.
8. Karino Y, Hige S, Matsushima T, Toyota J. Interstitial pneumonia induced by interferon therapy in type C hepatitis (in Japanese with English abstract). Nippon Rinsho 1994;52: 1905-9.
9. Bachleitner-Hofmann T, Gisslinger H. The role of interferon-alpha in the treatment of idiopathic myelofibrosis. Ann Hematol 1999;78:533-8.
10. Kirkwood J. Cancer immunotherapy: the interferon-alpha experience. Semin Oncol 2002;29:18-26.
11. Siegel RS, Kuzel TM. Cutaneous T-cell lymphoma/leukemia. Curr Treat Options Oncol 2000;1:43-50.
12. Agarwala S. Improving survival in patients with high-risk and metastatic melanoma: immunotherapy leads the way. Am J Clin Dermatol 2003;4:333-46.
13. Yamamoto S, Tomita Y, Nakamori S, Hoshida Y, Nagano H, Dono K, et al. Elevated expression of valosin-containing protein (p97) in hepatocellular carcinoma is correlated with increased incidence of tumor recurrence. J Clin Oncol 2003;21:447-52.
14. Nagai S, Kitaichi M, Izumi T. Classification and recent advances in idiopathic interstitial pneumonia. Curr Opin Pulm Med 1998; 4:256-60.
15. Katzenstein AL, Myers JL. Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am J Respir Crit Care Med 1998;157:1301-15.
16. Trisolini R, Lazzari Agli L, Tassinari D, Rondelli D, Cancellieri A, Patelli M, et al. Acute lung injury associated with 5-fluorouracil and oxaliplatinum combined chemotherapy. Eur Respir J 2001;18:243-5.
17. Anderson P, Hoglund M, Rodjer S. Pulmonary side effects of interferon-alpha therapy in patients with hematological malignancies. Am J Hematol 2003;73:54-8.
18. Sacchi S, Kantarjian H, O'Brien S, Cohen PR, Pierce S, Talpaz M. Immune-mediated and unusual complications during interferon alfa therapy in chronic myelogenous leukemia. J Clin Oncol 1995;13:2401-7.